Gait Initiation and Transition From Double to Single Support in Patients With Unilateral Primary Coxarthrosis
NCT ID: NCT06258369
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
100 participants
INTERVENTIONAL
2024-02-19
2027-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients included in the study will undergo a three-dimensional gait analysis. Dynamic gait analysis is multidimensional, measuring kinematic parameters (joint amplitudes: ankles, knees, hips, etc.) and dynamic parameters (assessment of joint torque from ankle, knee, hip to lower limb during gait initiation).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analysis of Biomechanical Parameters and Return to Sport After Total Hip Replacement
NCT06803914
Gait After THA: Direct Anterior vs Manual Posterior vs Robotic Posterior
NCT07226973
Evaluation of a New Navigation System in Computer-assisted Total Knee Arthroplasty
NCT05435690
Gait Analysis and Clinical Outcomes of Anterior and Lateral Approach Total Hip Arthroplasty.
NCT06538519
Efficiency and Safety of Navigation Aids in Total Hip Arthroplasty With Direct Anterior Approach
NCT07134036
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
Patients with coxarthrosis (any stage) with THP (Total Hip replacement)
Patients with coxarthrosis (any stage) with RHT (Hip resurfacing)
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with primary coxarthrosis (any stage).
Patients with primary coxarthrosis (any stage).
Patients who do not undergo surgery will be called specifically for the study to attend a consultation dedicated to gait assessment.
Patients with primary coxarthrosis (any stage) and operated with Total Hip prosthesis (THP).
Patients with primary coxarthrosis (any stage) and operated with Total Hip Prosthesis (THP).
Patients scheduled for THP (Total Hip Prosthesis) will be seen at the consultation the day before surgery, in the same hospital as the THP, or at an existing dedicated consultation scheduled for all THP patients. During these scheduled visits, they will be received in the gait analysis laboratory for a gait assessment (V1). Patients will be seen again at 6 months post-operatively for a second gait assessment (V2).
Patients with primary coxarthrosis (any stage) and operated with RTH (Hip resurfacing).
Patients with primary coxarthrosis (any stage) and operated with RTH (Hip resurfacing).
Patients scheduled for RTH (Hip Resurfacing) will be seen at the consultation the day before surgery, in the same hospital as the RTH, or at an existing dedicated consultation scheduled for all RTH patients. During these scheduled visits, they will be received in the gait analysis laboratory for a gait assessment (V1). Patients will be seen again at 6 months post-operatively for a second gait assessment (V2).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patients with primary coxarthrosis (any stage).
Patients who do not undergo surgery will be called specifically for the study to attend a consultation dedicated to gait assessment.
Patients with primary coxarthrosis (any stage) and operated with Total Hip Prosthesis (THP).
Patients scheduled for THP (Total Hip Prosthesis) will be seen at the consultation the day before surgery, in the same hospital as the THP, or at an existing dedicated consultation scheduled for all THP patients. During these scheduled visits, they will be received in the gait analysis laboratory for a gait assessment (V1). Patients will be seen again at 6 months post-operatively for a second gait assessment (V2).
Patients with primary coxarthrosis (any stage) and operated with RTH (Hip resurfacing).
Patients scheduled for RTH (Hip Resurfacing) will be seen at the consultation the day before surgery, in the same hospital as the RTH, or at an existing dedicated consultation scheduled for all RTH patients. During these scheduled visits, they will be received in the gait analysis laboratory for a gait assessment (V1). Patients will be seen again at 6 months post-operatively for a second gait assessment (V2).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With primary coxarthrosis (any stage)
* Consulting in the orthopedic departments of participating centers in anticipation of hip surgery (PTH/RTH), or for advice only.
* Written consent signed by the patient
* Affiliation with a social security scheme
Exclusion Criteria
Symptomatic contralateral hip/knee disease Symptomatic gonarthrosis or homolateral total knee prosthesis History of surgery on the affected hip History of fracture of the lower limb in the past year History of lower limb sprain in the last 3 months Neurological or degenerative disease
* Pregnant or breast-feeding
* Adults under guardianship, curatorship or safeguard of justice
* Cognitive impairment making it impossible to understand the protocol
* Approach other than Moore posterolateral (for PTH and RTH groups)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lille Catholic University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre MARTINOT, MD
Role: STUDY_DIRECTOR
Hôpital Saint Philibert, GHICL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Lille
Lille, , France
Hôpital Saint-Philibert (GHICL)
Lomme, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC-P00122
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.